SHShigeki Higashiyama

Shigeki Higashiyama

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Shigeki Higashiyama has a total of 33 co-authors. Here are the top co-authors by number of shared publications:

  • Naoyuki Taniguchi

    4 shared publications
  • Yuji Matsuzawa

    2 shared publications
  • Hiroshi Ishiguro

    Departments of Internal Medicine, Osaka University Medical School 2-2 Yamadaoka, Suita, Osaka 565

    1 shared publication
  • Jun-Ichiro Miyagawa

    The Second Department of Internal Medicine (T.I., S.K., J.M., Y.I., S.T., K.F., K.I., K.Y., Y.M.) and Department of Biochemistry (N.T., S.H.), Osaka (Japan) University Medical School

    1 shared publication
  • Junichiro Miyagawa

    Institute for Comprehensive Medical Science, Fujita Health University Toyoake, Aichi 470-11

    1 shared publication
  • Katsumi Yamamori

    The Second Department of Internal Medicine (T.I., S.K., J.M., Y.I., S.T., K.F., K.I., K.Y., Y.M.) and Department of Biochemistry (N.T., S.H.), Osaka (Japan) University Medical School

    1 shared publication

Latest Publications

    • 1 November 2002
      • Vol. 62  (21) , 6289-96

    Roles of cell adhesion molecules in tumor angiogenesis induced by cotransplantation of cancer and endothelial cells to nude rats.

    by Kou Tei, Naoko Kawakami-Kimura, Osamu Taguchi, Kensuke Kumamoto, Shigeki Higashiyama, Naoyuki Taniguchi, Ken'Ichi Toda, Ryo Kawata, Yasuo Hisa, Reiji Kannagi

    Roles of cell adhesion molecules mediating the interaction of cancer and endothelial cells in tumor angiogenesis were investigated using new in vitro and in vivo model systems with a cultured murine endothelial cell line (F-2) and human cultured epidermoid cancer cells (A431). The A431 cells exhibited typical in vitro cell adhesion to the endothelial F-2 cells. The initial step of adhesion was mediated by sialyl Lewis(x) (Le(x)) and sialyl Le(a), the carbohydrate determinants expressed on the cancer cells, and E-selectin expressed constitutively on F-2 cells. Prolonged culture led to the implantation of cancer cells into the monolayer of the F-2 cells, which was mediated mainly by alpha(3)beta(1)-integrin. F-2 cells cultured on Matrigel showed evident tube formation, and coculture of F-2 cells with A431 cells led to the formation of A431 cell nests constantly surrounded by tube-like networks consisting of F-2 cells. This in vitro morphogenesis was inhibited by the addition of anti-sialyl Le(x)/Le(a) or anti-beta(1)-integrin antibodies, which led to the formation of cancer cell aggregates that were independent from the F-2 cell networks. This in vitro morphological appearance was exactly reproduced in the in vivo tumors, which were formed when the mixture of A431 and F-2 cells at the ratio of 10:1 were cotransplanted s.c. into the back of nude rats. The tumors of A431 supplemented with F-2 cells were profoundly vascularized throughout by the tubular structures formed by F-2 cells, the lumen of which contained the host rat blood cells. The tumor mass thus formed was an average 5.8-fold as large as control A431 tumors that were grown without F-2 cells. The co-injection of anti-Le(x)/Le(a) or anti-beta(1)-integrin antibodies produced a marked reduction in the size of A431 tumors, which were not vascularized and accompanied an independent tiny remnant clump of F-2 cells. The size of these A431 tumors did not differ significantly from those of control A431 tumors raised without F-2 cells. These results indicate that the interaction of tumor cells and endothelial cells in orderly tumor angiomorphogenesis is highly dependent on the action of cell adhesion molecules mediating the adhesion of cancer cells to endothelial cells, inhibition of which remarkably retards tumor growth and angiogenesis.


  • Gastrin induces heparin-binding EGF-like growth factor in rat gastric epithelial cells transfected with gastrin receptor

    by Yoshiji Miyazaki, Yasuhisa Shinomura, Shusaku Tsutsui, Shinichiro Zushi, Yoshifumi Higashimoto, Shuji Kanayama, Shigeki Higashiyama, Naoyuki Taniguchi, Yuji Matsuzawa

  • A Novel Brain-Derived Member of the Epidermal Growth Factor Family That Interacts with ErbB3 and ErbB4

    by Shigeki Higashiyama, Michiharu Horikawa, Kouji Yamada, Naohiro Ichino, Norihiko Nakano, Takatoshi Nakagawa, Junichiro Miyagawa, Natsuki Matsushita, Toshiharu Nagatsu, Naoyuki Taniguchi, et al.

    A novel member of the epidermal growth factor (EGF) family, the neural- and thymus-derived activator for ErbB kinases (NTAK), has been purified and cloned. Five alternative spliced isoforms have been detected in the rat adrenal pheochromocytoma cell line, PC-12 cells. The rat NTAKα2a isoform exhibits 94% identity in its primary sequence with the human NTAKα isoform. In vivo, NTAK is only expressed in the brain of rat E11.5 embryos, and in the brain and thymus of adult rats. The soluble 46 kDa form binds directly to ErbB3 and B4, but not to ErbB1 or B2. NTAK, however, transactivates ErbB1 and B2 via heterodimerization with ErbB3 or B4. NTAK stimulates the differentiation of MDA-MB-453 cells and competitively inhibits the binding of [125I]neuregulin to these cells. In addition to these neuregulin-like properties, NTAK exhibits limited structural homology to neuregu-lins in the immunoglobulin (Ig)-like, EGF-like, and hydrophobic domains. Thus, NTAK appears to be a new member of the EGF family displaying neuregulin properties.


  • Expression of Heparin-Binding Epidermal Growth Factor–Like Growth Factor in Neointimal Cells Induced by Balloon Injury in Rat Carotid Arteries

    by Takumi Igura, Sumio Kawata, Jun-Ichiro Miyagawa, Yoshiaki Inui, Shinji Tamura, Kazuto Fukuda, Koji Isozaki, Katsumi Yamamori, Naoyuki Taniguchi, Shigeki Higashiyama, et al.

    Balloon catheter injury of rat carotid arteries induces migration and proliferation of smooth muscle cells (SMCs), with subsequent neointimal formation. Several growth factors, such as platelet-derived growth factor and basic fibroblast growth factor, have been shown to be involved in this process, but the mechanisms that modulate the growth and/or migratory properties of SMCs remain unclear. In this study, we investigated whether heparin-binding epidermal growth factor–like growth factor (HB-EGF), which is known to be a potent SMC stimulator from in vitro study, is associated with the proliferative response of SMCs to arterial injury. Northern blot analysis showed that the transcript levels of HB-EGF increased rapidly approximately 12-fold within 2 hours after injury and declined by 2 days but remained 3-fold at 14 days. In situ hybridization analysis demonstrated that the transcript of HB-EGF remained strongly expressed in the neointima, especially near the luminal surface, at 14 days after injury. Immunohistochemical staining showed that HB-EGF protein was positive in the endothelium and only faintly visible in medial SMCs in uninjured vessels. In contrast, 2 days after injury, positive HB-EGF immunostaining was detected in the medial SMCs along the luminal surface. At 7 days, the neointimal SMCs exhibited strong immunostaining for HB-EGF, and at 14 days, they exhibited a gradient of HB-EGF expression with strong immunoreactivity in the most luminal cells. SMCs labeled with 5-bromo-2′-deoxyuridine in their nuclei showed strong immunostaining for HB-EGF protein. Furthermore, the epidermal growth factor receptor to which HB-EGF can bind was also immunostained positively in neointimal SMCs. These data suggest that HB-EGF may play an important role of the proliferation and migration of SMCs in the process of neointimal accumulation induced by arterial injury, probably in an autocrine, paracrine, and/or juxtacrine manner.